Tick-Borne Disease Prevention and Research Reauthorization Act of 2025

This Act reauthorizes the Kay Hagan Tick Act through fiscal year 2030. The Secretary of Health and Human Services shall administer a competitive grant program for states, tribes, and territories to fund tick-borne disease surveillance, public education, diagnostic improvement, and research into prevention and treatment. Grants may be used for vector control, community outreach, and workforce training. No federal funds may be used for any activity that restricts lawful hunting, trapping, or pesticide use beyond existing federal or state law. Each grant recipient must provide a 25% non-federal match, which may include in-kind contributions. The Secretary shall establish a Tick-Borne Disease Advisory Committee comprising representatives from affected states, academic researchers, private industry, and patient advocacy groups. The Committee shall report annually on program effectiveness, emerging threats, and recommendations for best practices. Total appropriations for this Act are capped at $100 million over five fiscal years, to be drawn from the Prevention and Public Health Fund established under section 4002 of the Patient Protection and Affordable Care Act. No funds may be used for any activity not directly related to tick-borne diseases. The authority to make grants expires on September 30, 2030, and any unobligated balances shall revert to the Treasury. Enforcement: The Inspector General of the Department of Health and Human Services shall audit grant recipients for compliance with matching requirements, allowable uses, and reporting. Any recipient found to have misused funds shall be required to repay the full amount plus interest and shall be ineligible for future grants under this Act for five years. Effective date: October 1, 2025.